PubRank

Katri Pylkäs

Author PubWeight™ 72.44‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Large-scale genotyping identifies 41 new loci associated with breast cancer risk. Nat Genet 2013 8.24
2 Breast-cancer risk in families with mutations in PALB2. N Engl J Med 2014 4.97
3 A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor-negative breast cancer in the general population. Nat Genet 2010 4.96
4 A recurrent mutation in PALB2 in Finnish cancer families. Nature 2007 4.64
5 Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies. J Natl Cancer Inst 2010 4.54
6 Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer. Nat Genet 2013 4.35
7 Genome-wide association studies identify four ER negative-specific breast cancer risk loci. Nat Genet 2013 3.81
8 A common variant at the TERT-CLPTM1L locus is associated with estrogen receptor-negative breast cancer. Nat Genet 2011 3.37
9 Genome-wide association analysis identifies three new breast cancer susceptibility loci. Nat Genet 2012 3.20
10 Functional variants at the 11q13 risk locus for breast cancer regulate cyclin D1 expression through long-range enhancers. Am J Hum Genet 2013 2.24
11 19p13.1 is a triple-negative-specific breast cancer susceptibility locus. Cancer Res 2012 1.81
12 Penetrance analysis of the PALB2 c.1592delT founder mutation. Clin Cancer Res 2008 1.65
13 Common breast cancer susceptibility loci are associated with triple-negative breast cancer. Cancer Res 2011 1.65
14 Associations of common variants at 1p11.2 and 14q24.1 (RAD51L1) with breast cancer risk and heterogeneity by tumor subtype: findings from the Breast Cancer Association Consortium. Hum Mol Genet 2011 1.56
15 Fine-scale mapping of the FGFR2 breast cancer risk locus: putative functional variants differentially bind FOXA1 and E2F1. Am J Hum Genet 2013 1.39
16 11q13 is a susceptibility locus for hormone receptor positive breast cancer. Hum Mutat 2012 1.26
17 Further evidence for the contribution of the RAD51C gene in hereditary breast and ovarian cancer susceptibility. Breast Cancer Res Treat 2011 1.24
18 Confirmation of 5p12 as a susceptibility locus for progesterone-receptor-positive, lower grade breast cancer. Cancer Epidemiol Biomarkers Prev 2011 1.23
19 The role of genetic breast cancer susceptibility variants as prognostic factors. Hum Mol Genet 2012 1.23
20 Comparison of 6q25 breast cancer hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC). PLoS One 2012 1.13
21 Breast cancer-associated Abraxas mutation disrupts nuclear localization and DNA damage response functions. Sci Transl Med 2012 1.07
22 Heterozygous mutations in PALB2 cause DNA replication and damage response defects. Nat Commun 2013 1.02
23 A large-scale assessment of two-way SNP interactions in breast cancer susceptibility using 46,450 cases and 42,461 controls from the breast cancer association consortium. Hum Mol Genet 2013 1.00
24 Refined histopathological predictors of BRCA1 and BRCA2 mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia. Breast Cancer Res 2014 0.99
25 9q31.2-rs865686 as a susceptibility locus for estrogen receptor-positive breast cancer: evidence from the Breast Cancer Association Consortium. Cancer Epidemiol Biomarkers Prev 2012 0.95
26 Genome-wide search for breast cancer linkage in large Icelandic non-BRCA1/2 families. Breast Cancer Res 2010 0.93
27 Mutation screening of the MERIT40 gene encoding a novel BRCA1 and RAP80 interacting protein in breast cancer families. Breast Cancer Res Treat 2009 0.90
28 BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers. J Natl Cancer Inst 2015 0.90
29 Inactivation of Palb2 gene leads to mesoderm differentiation defect and early embryonic lethality in mice. Hum Mol Genet 2010 0.87
30 Screening for large genomic rearrangements in the FANCA gene reveals extensive deletion in a Finnish breast cancer family. Cancer Lett 2011 0.84
31 Evaluation of the need for routine clinical testing of PALB2 c.1592delT mutation in BRCA negative Northern Finnish breast cancer families. BMC Med Genet 2013 0.82
32 The UGT1A6_19_GG genotype is a breast cancer risk factor. Front Genet 2013 0.82
33 Germline alterations in the CLSPN gene in breast cancer families. Cancer Lett 2008 0.82
34 Mutation analysis of the AATF gene in breast cancer families. BMC Cancer 2009 0.78
35 Recurrent CYP2C19 deletion allele is associated with triple-negative breast cancer. BMC Cancer 2014 0.78
36 Mutation analysis of the gene encoding the PALB2-binding protein MRG15 in BRCA1/2-negative breast cancer families. J Hum Genet 2010 0.77
37 Haplotypes of the I157T CHEK2 germline mutation in ethnically diverse populations. Fam Cancer 2009 0.77
38 Screening for large genomic rearrangements of the BRIP1 and CHK1 genes in Finnish breast cancer families. Fam Cancer 2010 0.77
39 Mutation screening of the RNF8, UBC13 and MMS2 genes in Northern Finnish breast cancer families. BMC Med Genet 2011 0.75